Correction to: Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device’s patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMechanical Circulatory Support Devices · Cardiac Arrhythmias and Treatments · Cardiac pacing and defibrillation studies
This is a correction to: Petr Peichl, Antoni Bayes-Genis, Thomas Deneke, Ovidiu Chioncel, Marta deRiva, Maria Generosa Crespo-Leiro, Antonio Frontera, Finn Gustafsson, Raphaël P Martins, Matteo Pagnesi, Philippe Maury, Mark C Petrie, Frederic Sacher, Offer Amir, Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device’s patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, EP Europace, Volume 26, Issue 11, November 2024, euae272, https://doi.org/10.1093/europace/euae272
The following changes have been made to the originally published manuscript. The names and affiliations for the reviewers have been removed from the author list and replaced within a separate section in the body of the article.